The academic research appeal of medical device epidemiology appears to have lagged far behind that of pharmacoepidemiology. This lag appears to be related to several fundamental differences between drugs or biologics and medical devices, because of classification or identification schemes employed in the USA that impact ease of exposure discernment and cataloging of academic literature describing medical device epidemiology.

This chapter focuses on these differences through a review of existing literature, contrasts with pharmacoepidemiology, and listing of some research challenges and opportunities, and concludes with recommendations for future research.

Was this article helpful?

0 0

Post a comment